SynthesisMedical oncology (Northwood, London, England)2015

Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.

Li Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.